Oncology & Cancer

Study provides new look at why rare cancer often evades treatments

Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often ...

Medications

Empagliflozin improves HbA1c in young people with T2DM

For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.

page 4 from 14